Yvonne Linney

Yvonne Linney

Director/Board Member at BIONANO GENOMICS, INC.

Net worth: - $ as of 31/05/2026

64 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Yvonne Linney is an Independent Director at Bionano Genomics, Inc. and a Member at Women in Bio, Inc. She is on the Board of Directors at Bionano Genomics, Inc. Dr. Linney was previously employed as a Chief Operating Officer & Director by Artificial, Inc., an Executive VP & General Manager-Life Sciences by Agilent Technologies, Inc., a Director-Molecular Diagnostics by Bayer HealthCare Ltd., a Senior Director-Marketing & Product Management by Caliper Life Sciences, Inc., a Director-Genomics by GE Healthcare Ltd. (United Kingdom), and a Chief Executive Officer by Transcriptic, Inc. She also served on the board at Sengenics Corp.
Pte Ltd. She received her undergraduate degree from the University of Warwick and a doctorate degree from the University of Leicester.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/05/2026 0 ( -.--% ) - $ 31/05/2026

Yvonne Linney active positions

CompaniesPositionStart
BIONANO GENOMICS, INC. Director/Board Member 04/05/2020
Corporate Officer/Principal 01/07/2019

Former positions of Yvonne Linney

CompaniesPositionEnd
Director/Board Member 01/12/2024
Chief Operating Officer 01/09/2022
AGILENT TECHNOLOGIES, INC. Corporate Officer/Principal 01/01/2015
Bayer HealthCare Ltd.
Corporate Officer/Principal 01/01/2006
Corporate Officer/Principal 01/01/2005
See the detail of Yvonne Linney's experience

Training of Yvonne Linney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Bayer HealthCare Ltd.

Technology Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!